VintaBio Opens Custom-built Manufacturing Facility in Philadelphia for CGTs

SourceContract Pharma
Date Published04/13/2023
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name VintaBio
Type of work Manufacturing
Reshoring category:Reshoring
Year reshoring announced:2023
Capital investment ($):64
City reshored to:Philadelphia
State(s) reshored to:PA
If relevant, work nearshored to:-
Product(s) reshoredviral vectors, cell, gene therapy
Find Reshoring Articles